COVID-19 Imposes Challenges on Pharma
There’s never been a better time to go virtual; Stefanini has reimagined solutions that allow our clients to rethink their industry processes: we aim to help our clients Convert to Digital.
COVID-19 has impacted every component of the pharma industry: Research and Discovery, Clinical R&D, Quality & Regulatory, Manufacturing and Supply Chain. Amidst all of this uncertainty, pharma companies have additional pressure to conduct faster clinical trials and work on finding either a vaccination or cure for COVID-19.
The Stefanini Advantage
While we forge ahead through the COVID-19 crisis, CliniTRUST is here to help lessen your worries; that’s why we are offering a free six month trial to pharma companies who are conducting COVID-19 related studies.
Why wait? There’s no better time than now to work with Stefanini and face challenges posed by the pharma industry head-on.
The Stefanini Life Sciences Unit aims to co-innovate and co-create digital solutions that enable organizations to conduct faster R&D, trials and better patient care, all leading to solutions that companies and patients can TRUST:
Hi. Need help?